BC
SUPN icon

Burney Company’s Supernus Pharmaceuticals SUPN Stock Holding History

Burney Company’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Sell
4,325
-556
-11% -$26.7K 0.01% 598
2026
Q1 		$252K Sell
4,881
-3,090
-39% -$157K 0.01% 536
2025
Q4 		$396K Sell
7,971
-67
-0.8% -$3.26K 0.01% 478
2025
Q3 		$384K Sell
8,038
-248
-3% -$9.99K 0.01% 462
2025
Q2 		$261K Sell
8,286
-52,587
-86% -$1.69M 0.01% 513
2025
Q1 		$1.99M Sell
60,873
-22,279
-27% -$789K 0.07% 212
2024
Q4 		$3.01M Buy
83,152
+71,331
+603% +$2.51M 0.11% 174
2024
Q3 		$369K Sell
11,821
-3,032
-20% -$94.6K 0.01% 481
2024
Q2 		$397K Sell
14,853
-6,366
-30% -$185K 0.02% 461
2024
Q1 		$724K Sell
21,219
-383
-2% -$11.4K 0.03% 371
2023
Q4 		$625K Sell
21,602
-50,109
-70% -$1.33M 0.03% 391
2023
Q3 		$1.98M Sell
71,711
-114,648
-62% -$3.49M 0.09% 223
2023
Q2 		$5.6M Buy
186,359
+123,487
+196% +$4.32M 0.26% 102
2023
Q1 		$2.28M Buy
62,872
+357
+0.6% +$13.7K 0.11% 206
2022
Q4 		$2.23M Buy
62,515
+36,673
+142% +$1.27M 0.11% 192
2022
Q3 		$875K Sell
25,842
-12,825
-33% -$417K 0.05% 325
2022
Q2 		$1.12M Sell
38,667
-32,492
-46% -$931K 0.06% 279
2022
Q1 		$2.3M Sell
71,159
-1,845
-3% -$56.6K 0.11% 214
2021
Q4 		$2.13M Sell
73,004
-5,911
-7% -$179K 0.09% 230
2021
Q3 		$2.1M Sell
78,915
-4,655
-6% -$125K 0.1% 216
2021
Q2 		$2.57M Sell
83,570
-894
-1% -$27.4K 0.12% 205
2021
Q1 		$2.21M Sell
84,464
-18,038
-18% -$504K 0.11% 208
2020
Q4 		$2.58M Sell
102,502
-114,211
-53% -$2.46M 0.14% 184
2020
Q3 		$4.52M Buy
216,713
+50,736
+31% +$1.15M 0.28% 110
2020
Q2 		$3.94M Buy
+165,977
New +$3.67M 0.26% 120

Other funds holding SUPN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CNAM
Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Burney Company's SUPN Position: Q2 2026 in Review

Burney Company reduced its Supernus Pharmaceuticals (SUPN) stake by 11% in Q2 2026, selling an estimated $26.7K and leaving 4,325 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #598.

Burney Company first reported a position in SUPN in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.6M in Q2 2023. 41 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Burney Company held 4,325 shares of Supernus Pharmaceuticals worth $201K as of Q2 2026.
  • Burney Company sold 556 Supernus Pharmaceuticals shares in Q2 2026, an estimated $26.7K.
  • Supernus Pharmaceuticals made up 0.01% of Burney Company's portfolio in Q2 2026, its #598 holding.
  • Burney Company first reported a position in Supernus Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Burney Company's Supernus Pharmaceuticals position peaked at $5.6M in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.